These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 23230081)
21. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats. Mak P; Broadbear JH; Kolosov A; Goodchild CS Pain Med; 2015 Sep; 16(9):1781-93. PubMed ID: 25800174 [TBL] [Abstract][Full Text] [Related]
22. Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. He SQ; Zhang ZN; Guan JS; Liu HR; Zhao B; Wang HB; Li Q; Yang H; Luo J; Li ZY; Wang Q; Lu YJ; Bao L; Zhang X Neuron; 2011 Jan; 69(1):120-31. PubMed ID: 21220103 [TBL] [Abstract][Full Text] [Related]
23. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn. Wang D; Chen T; Zhou X; Couture R; Hong Y Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038 [TBL] [Abstract][Full Text] [Related]
24. The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system. Landa-Juárez AY; Pérez-Severiano F; Castañeda-Hernández G; Ortiz MI; Chávez-Piña AE Eur J Pharmacol; 2019 Feb; 845():32-39. PubMed ID: 30582909 [TBL] [Abstract][Full Text] [Related]
25. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. Banafshe HR; Hamidi GA; Noureddini M; Mirhashemi SM; Mokhtari R; Shoferpour M Eur J Pharmacol; 2014 Jan; 723():202-6. PubMed ID: 24315931 [TBL] [Abstract][Full Text] [Related]
26. Decreased spinal endomorphin-2 contributes to mechanical allodynia in streptozotocin-induced diabetic rats. Niu L; Dai GH; He GL; Yang M; Hu HM; Liu ZK; Qian NS; Chen YL Neurochem Int; 2017 Sep; 108():372-380. PubMed ID: 28532680 [TBL] [Abstract][Full Text] [Related]
27. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Christoph T; De Vry J; Tzschentke TM Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182 [TBL] [Abstract][Full Text] [Related]
28. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. Trafton JA; Abbadie C; Marek K; Basbaum AI J Neurosci; 2000 Dec; 20(23):8578-84. PubMed ID: 11102461 [TBL] [Abstract][Full Text] [Related]
29. Ultralow dose fentanyl prevents development of chronic neuropathic pain in rats. Wala EP; Holtman JR; Sloan PA J Opioid Manag; 2013; 9(2):85-96. PubMed ID: 23709318 [TBL] [Abstract][Full Text] [Related]
30. The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice. Kögel B; De Vry J; Tzschentke TM; Christoph T Neurosci Lett; 2011 Mar; 491(2):104-7. PubMed ID: 21232580 [TBL] [Abstract][Full Text] [Related]
31. Fentanyl produces an anti-hyperalgesic effect through the suppression of sodium channels in mice with painful diabetic neuropathy. Tanaka K; Nakanishi Y; Sekino S; Ikegami M; Ikeda H; Kamei J Eur J Pharmacol; 2014 Jun; 733():68-74. PubMed ID: 24704555 [TBL] [Abstract][Full Text] [Related]
32. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins. Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133 [TBL] [Abstract][Full Text] [Related]
33. Effect of selol on the opioids activity in streptozotocin induced hyperalgesia. Bujalska M; Winecka R; Gumułka SW Acta Pol Pharm; 2008; 65(6):691-6. PubMed ID: 19172850 [TBL] [Abstract][Full Text] [Related]
34. Fast modulation of μ-opioid receptor (MOR) recycling is mediated by receptor agonists. Roman-Vendrell C; Yu YJ; Yudowski GA J Biol Chem; 2012 Apr; 287(18):14782-91. PubMed ID: 22378794 [TBL] [Abstract][Full Text] [Related]
35. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524 [TBL] [Abstract][Full Text] [Related]
36. The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats. Xu X; Liu Z; Liu H; Yang X; Li Z Eur J Pharmacol; 2012 Apr; 680(1-3):28-33. PubMed ID: 22306246 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of antinociceptive effect of morphine by antidepressants in diabetic neuropathic pain model. Cegielska-Perun K; Bujalska-Zadrożny M; Gąsińska E; Makulska-Nowak HE Pharmacol Rep; 2014 Apr; 66(2):228-34. PubMed ID: 24911074 [TBL] [Abstract][Full Text] [Related]
38. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats. Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428 [TBL] [Abstract][Full Text] [Related]
39. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Zollner C; Shaqura MA; Bopaiah CP; Mousa S; Stein C; Schafer M Mol Pharmacol; 2003 Aug; 64(2):202-10. PubMed ID: 12869624 [TBL] [Abstract][Full Text] [Related]
40. The effect of benfotiamine on mu-opioid receptor mediated antinociception in experimental diabetes. Nacitarhan C; Minareci E; Sadan G Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):173-8. PubMed ID: 24643695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]